Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Pfizer reported second-quarter results that topped estimates and hiked the low end of its revenue outlook, citing the stronger-than-expected performance of non-Covid products.  The company is now expe...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。